hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Hypertension complicating T2DM with 1) CKD stage G2-G5 (eGFR<90mL/min/1.73m2) 2)Office BP>=130/80mmHg with ARB + amlodipine 5mg/day for at least 2 months 3)Out patients
Exclusion criteria
Exclusion criteria: 1) Dialysis patient 2) Nephrotic condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Delta morning home SBP measured during seventh to eighth week in each treatment phase | — |
Secondary
| Measure | Time frame |
|---|---|
| The difference between the early morning diastolic blood pressure, pulse, blood pressure at night, before bedtime blood pressure, the difference between the various types of test values, step-down target arrival rate, the drop-out rate of patients, side effects, of each treatment period | — |
Countries
Japan
Contacts
Tokyo Saiseikai Central Hospital Department of nephrology